Chinese General Practice ›› 2024, Vol. 27 ›› Issue (33): 4132-4138.DOI: 10.12114/j.issn.1007-9572.2024.0094
• Original Research • Previous Articles Next Articles
Received:
2024-04-08
Revised:
2024-06-10
Published:
2024-11-20
Online:
2024-08-08
Contact:
ZHANG Jing
通讯作者:
张晶
作者简介:
作者贡献:
戴承晔进行研究的构思、设计以及文章撰写;邓毅凡进行数据的收集、整理与统计学分析;何胜虎、张晶负责文章的修订;张晶负责文章的质量控制及审校,对文章整体负责,监督管理。
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0094
指标 | ACS组(n=184) | 对照组(n=141) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄(岁) | 66.3±8.6 | 65.6±8.1 | 0.783 | 0.434 |
BMI(kg/m2) | 25.2±3.5 | 22.3±2.8 | 8.111 | <0.001 |
吸烟[例(%)] | 37(20.1) | 8(5.7) | 10.573a | 0.001 |
饮酒[例(%)] | 20(10.9) | 10(7.1) | 1.359a | 0.331 |
高血压[例(%)] | 98(53.3) | 47(33.3) | 12.829a | <0.001 |
糖尿病[例(%)] | 54(29.4) | 27(19.1) | 4.438a | 0.048 |
LVEF[M(P25,P75),%] | 61(56,62) | 62(60,63) | -3.157b | 0.002 |
TG(mmol/L) | 1.49±1.28 | 1.38±0.91 | 0.855 | 0.393 |
TC(mmol/L) | 4.72±1.05 | 4.58±1.07 | 1.141 | 0.255 |
HDL-C(mmol/L) | 1.12±0.27 | 1.37±0.29 | -8.123 | <0.001 |
LDL-C(mmol/L) | 3.02±0.77 | 2.28±0.79 | 8.455 | <0.001 |
单核细胞计数(×109) | 0.39±0.15 | 0.31±0.14 | 4.547 | <0.001 |
TSH(mU/L) | 2.67±1.01 | 1.79±0.73 | 9.109 | <0.001 |
MHR | 0.37±0.17 | 0.24±0.13 | 7.793 | <0.001 |
Table 1 Baseline data results of ACS group and control group
指标 | ACS组(n=184) | 对照组(n=141) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄(岁) | 66.3±8.6 | 65.6±8.1 | 0.783 | 0.434 |
BMI(kg/m2) | 25.2±3.5 | 22.3±2.8 | 8.111 | <0.001 |
吸烟[例(%)] | 37(20.1) | 8(5.7) | 10.573a | 0.001 |
饮酒[例(%)] | 20(10.9) | 10(7.1) | 1.359a | 0.331 |
高血压[例(%)] | 98(53.3) | 47(33.3) | 12.829a | <0.001 |
糖尿病[例(%)] | 54(29.4) | 27(19.1) | 4.438a | 0.048 |
LVEF[M(P25,P75),%] | 61(56,62) | 62(60,63) | -3.157b | 0.002 |
TG(mmol/L) | 1.49±1.28 | 1.38±0.91 | 0.855 | 0.393 |
TC(mmol/L) | 4.72±1.05 | 4.58±1.07 | 1.141 | 0.255 |
HDL-C(mmol/L) | 1.12±0.27 | 1.37±0.29 | -8.123 | <0.001 |
LDL-C(mmol/L) | 3.02±0.77 | 2.28±0.79 | 8.455 | <0.001 |
单核细胞计数(×109) | 0.39±0.15 | 0.31±0.14 | 4.547 | <0.001 |
TSH(mU/L) | 2.67±1.01 | 1.79±0.73 | 9.109 | <0.001 |
MHR | 0.37±0.17 | 0.24±0.13 | 7.793 | <0.001 |
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.431 | 0.408 | 12.317 | <0.001 | 4.185 | 1.881~9.307 |
高血压 | 0.824 | 0.232 | 12.626 | <0.001 | 2.279 | 1.447~3.590 |
糖尿病 | 0.562 | 0.268 | 4.383 | 0.036 | 1.754 | 1.036~2.968 |
LVEF | -0.766 | 0.349 | 4.827 | 0.028 | 0.465 | 0.235~0.921 |
BMI | 1.932 | 0.259 | 55.693 | <0.001 | 6.905 | 4.157~11.470 |
HDL-C | -1.919 | 0.256 | 56.243 | <0.001 | 0.147 | 0.089~0.242 |
LDL-C | 2.338 | 0.446 | 27.426 | <0.001 | 10.357 | 4.318~24.843 |
单核细胞计数 | 0.503 | 0.321 | 2.455 | 0.117 | 1.653 | 0.882~3.101 |
TSH | 1.897 | 0.251 | 57.154 | <0.001 | 6.667 | 4.077~10.902 |
MHR | 1.913 | 0.250 | 58.434 | <0.001 | 6.772 | 4.147~11.506 |
Table 2 Univariate Logistic regression analysis of ACS influencing factors in menopausal women
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.431 | 0.408 | 12.317 | <0.001 | 4.185 | 1.881~9.307 |
高血压 | 0.824 | 0.232 | 12.626 | <0.001 | 2.279 | 1.447~3.590 |
糖尿病 | 0.562 | 0.268 | 4.383 | 0.036 | 1.754 | 1.036~2.968 |
LVEF | -0.766 | 0.349 | 4.827 | 0.028 | 0.465 | 0.235~0.921 |
BMI | 1.932 | 0.259 | 55.693 | <0.001 | 6.905 | 4.157~11.470 |
HDL-C | -1.919 | 0.256 | 56.243 | <0.001 | 0.147 | 0.089~0.242 |
LDL-C | 2.338 | 0.446 | 27.426 | <0.001 | 10.357 | 4.318~24.843 |
单核细胞计数 | 0.503 | 0.321 | 2.455 | 0.117 | 1.653 | 0.882~3.101 |
TSH | 1.897 | 0.251 | 57.154 | <0.001 | 6.667 | 4.077~10.902 |
MHR | 1.913 | 0.250 | 58.434 | <0.001 | 6.772 | 4.147~11.506 |
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.185 | 0.543 | 4.764 | 0.029 | 3.271 | 1.129~9.478 |
高血压 | 0.892 | 0.335 | 7.067 | 0.008 | 2.439 | 1.264~4.707 |
糖尿病 | 0.174 | 0.393 | 0.197 | 0.657 | 0.840 | 0.389~1.814 |
LVEF | -0.632 | 0.515 | 1.505 | 0.220 | 0.532 | 0.194~1.458 |
BMI | 1.662 | 0.335 | 24.547 | <0.001 | 5.268 | 2.730~10.166 |
HDL-C | -1.113 | 0.359 | 9.630 | 0.002 | 0.328 | 0.163~0.664 |
LDL-C | 1.703 | 0.588 | 8.385 | 0.004 | 5.488 | 1.734~17.372 |
TSH | 1.895 | 0.332 | 32.578 | <0.001 | 6.652 | 3.470~12.751 |
MHR | 0.975 | 0.351 | 7.729 | 0.005 | 2.652 | 1.333~5.276 |
Table 3 Multivariate Logistic regression analysis of influencing factors of ACS in menopausal women
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.185 | 0.543 | 4.764 | 0.029 | 3.271 | 1.129~9.478 |
高血压 | 0.892 | 0.335 | 7.067 | 0.008 | 2.439 | 1.264~4.707 |
糖尿病 | 0.174 | 0.393 | 0.197 | 0.657 | 0.840 | 0.389~1.814 |
LVEF | -0.632 | 0.515 | 1.505 | 0.220 | 0.532 | 0.194~1.458 |
BMI | 1.662 | 0.335 | 24.547 | <0.001 | 5.268 | 2.730~10.166 |
HDL-C | -1.113 | 0.359 | 9.630 | 0.002 | 0.328 | 0.163~0.664 |
LDL-C | 1.703 | 0.588 | 8.385 | 0.004 | 5.488 | 1.734~17.372 |
TSH | 1.895 | 0.332 | 32.578 | <0.001 | 6.652 | 3.470~12.751 |
MHR | 0.975 | 0.351 | 7.729 | 0.005 | 2.652 | 1.333~5.276 |
指标 | AUC | 95%CI | P值 | 最佳截断值 | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|---|---|
MHR | 0.777 | 0.725~0.830 | <0.001 | 0.255 | 76.1 | 72.3 |
TSH | 0.747 | 0.694~0.800 | <0.001 | 2.130 mU/L | 69.6 | 74.5 |
联合预测指标 | 0.810 | 0.764~0.857 | <0.001 | 0.513 | 77.7 | 73.0 |
Table 4 Diagnostic value of MHR,TSH and combined prediction of ACS in menopausal women
指标 | AUC | 95%CI | P值 | 最佳截断值 | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|---|---|
MHR | 0.777 | 0.725~0.830 | <0.001 | 0.255 | 76.1 | 72.3 |
TSH | 0.747 | 0.694~0.800 | <0.001 | 2.130 mU/L | 69.6 | 74.5 |
联合预测指标 | 0.810 | 0.764~0.857 | <0.001 | 0.513 | 77.7 | 73.0 |
指标 | 低危亚组(n=59) | 中危亚组(n=64) | 高危亚组(n=61) | F值 | P值 |
---|---|---|---|---|---|
MHR | 0.29±0.11 | 0.36±0.15a | 0.45±0.19ab | 15.401 | <0.05 |
TSH(mU/L) | 2.27±1.06 | 2.61±0.90a | 3.11±0.92ab | 11.211 | <0.05 |
Table 5 Comparison of MHR and TSH levels in low-risk subgroup,medium-risk subgroup and high-risk subgroup
指标 | 低危亚组(n=59) | 中危亚组(n=64) | 高危亚组(n=61) | F值 | P值 |
---|---|---|---|---|---|
MHR | 0.29±0.11 | 0.36±0.15a | 0.45±0.19ab | 15.401 | <0.05 |
TSH(mU/L) | 2.27±1.06 | 2.61±0.90a | 3.11±0.92ab | 11.211 | <0.05 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. DOI:10.3760/cma.j.cn115791-20210221-00095.
|
[8] |
刘强. 血尿酸水平与冠心病及其严重程度相关性的研究[D]. 唐山:唐山华北理工大学,2023. DOI:10.27108/d.cnki.ghelu.2023.001356.
|
[9] |
张新超,于学忠,陈凤英,等. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 临床急诊杂志,2019,20(4):253-262. DOI:10.13201/j.issn.1009-5918.2019.04.001.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[1] | LIANG Hong, ZHANG Ying, XU Hanping, YE Aoxing, WU Lingling, ZHAO Jing. The Health Characteristics and Health Needs of Perimenopausal Women in the Community [J]. Chinese General Practice, 2024, 27(34): 4286-4294. |
[2] | ZUO Zhongqi, WANG Yu, JIN Yan, ZHANG Qingwei, YUAN Binbin, SHEN Saiya, WANG Fei, YU Man. Early Warning Assessment Tools for Cardiovascular Disease Risk: a Scoping Review [J]. Chinese General Practice, 2024, 27(27): 3440-3445. |
[3] | LI Yong, LI Zhanhu, JIN Bowei, LI Yuan, ZHANG Hongbo, SU Yakun, YAN Xiaoju. Correlation between Serum Complement C1q/Tumor Necrosis Factor-related Protein 5 Levels and the Severity of Coronary Artery Lesions and Myocardial Fibrosis Markers in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(27): 3365-3371. |
[4] | HU Guiping, LIN Ping, ZHAO Zhenjuan, WANG Yini, YAN Mingqiang, SUN Xiao. Relationship between Dietary Inflammatory Potential and Severity of Coronary Artery Disease in Acute Coronary Syndrome Patients [J]. Chinese General Practice, 2024, 27(24): 3000-3006. |
[5] | HE Junhui, WAN Daguo, DONG Jing, ZHANG Juan. Correlation Analysis between Pan-immune Inflammatory Value, Systemic Immune-inflammatory Index, and Vulnerable Plaques in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(24): 2976-2981. |
[6] | HUANG Shuwei, ZHOU Zhiheng, FENG Tianyuan, LIU Li, DENG Guangpu, LI Yaotian, ZHU Hong. Study on the Predictive Value of Different Insulin Resistance Replacement Indices for Hyperuricemia in Middle-aged and Elderly Patients with Type 2 Diabetes [J]. Chinese General Practice, 2024, 27(19): 2364-2374. |
[7] | GONG Yue, HUANG Yueqing, ZHANG Liang, ZHAO Chunhua, HUANG Min. External Validation of a 10-year Cardiovascular Risk Assessment Tool Based on an Older Population [J]. Chinese General Practice, 2024, 27(19): 2336-2343. |
[8] | DIAO He, BAI Wenpei, ZHAO Lidong. Chemical Composition and Mechanism of Zuoci Pill in Treating Perimenopausal Hearing Loss Based on Network Pharmacology and Molecular Docking Technology [J]. Chinese General Practice, 2024, 27(12): 1493-1503. |
[9] | LU Ran, WU Chunyan, XU Haina, AN Miaomiao, WU Baoqin, LAI Jun, RAN Limei. A Threshold Study of Carotid Plaque Risk in Postmenopausal Middle-aged Women with Normal Homocysteine [J]. Chinese General Practice, 2024, 27(11): 1320-1325. |
[10] | YANG Mukun, JIA Xiaoxiang, REN Zhenghong, GU Bei, BAI Wenpei. Menopause or Chronologic Aging? A Prospective Cohort Study on Risk Factors for Coronary Heart Disease in Middle-aged Women [J]. Chinese General Practice, 2024, 27(03): 280-285. |
[11] | LIN Lingjun, GUO Jun, WANG Junwei, GAO Yang, CHEN Huiying, WAN Yongli. A Systematic Review of Risk Prediction Models for Diabetic Foot Development [J]. Chinese General Practice, 2024, 27(03): 357-363. |
[12] | JIA Yu, ZHOU Zitong, CAO Xuehua, HU Wanqin, XIANG Feng, XIONG Langyu, WANG Xiaoxia. Incidence of Perimenopausal Syndrome in Chinese Women Aged 40 to 65 Years: a Meta-analysis [J]. Chinese General Practice, 2023, 26(32): 4080-4088. |
[13] | HE Jingyi, WANG Fang, SHUI Xiaoling, LI Ling, LIANG Qian. Efficacy of Non-pharmacological Interventions to Improve Perimenopausal Insomnia Symptoms: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(31): 3963-3974. |
[14] | YAN Haihao, ZHANG Feifei, DANG Yi. Correlation of Remnant Cholesterol with Vulnerable Plaque Characteristics in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2023, 26(26): 3303-3307. |
[15] | Climacteric Health Care Branch of Chinese Preventive Medicine Association, Gynecologic Endocrinology and Fertility Professional Committees of China Association for Promotion of Health Science and Technology, Professional Committees of Beijing Association of the Integrating of Traditional and Western Medicine. Chinese Expert Consensus on Clinical Management of Menopause-related Insomnia [J]. Chinese General Practice, 2023, 26(24): 2951-2958. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||